Patient Safety Authority Logo

Skip navigation links
HOME
PATIENT SAFETY AUTHORITYExpand PATIENT SAFETY AUTHORITY
PA-PSRS and PASSKEYExpand PA-PSRS and PASSKEY
PATIENT SAFETY ADVISORIESExpand PATIENT SAFETY ADVISORIES
PATIENTS AND CONSUMERSExpand PATIENTS AND CONSUMERS
NEWS AND INFORMATIONExpand NEWS AND INFORMATION
COLLABORATIONSExpand COLLABORATIONS
EDUCATIONAL TOOLSExpand EDUCATIONAL TOOLS
AUTHORITY EVENTSExpand AUTHORITY EVENTS







ADDRESS:

Patient Safety Authority
333 Market Street
Lobby Level
Harrisburg, PA 17120


Phone: 717-346-0469
Fax: 717-346-1090


 
Advisory Banner
The Beers Criteria: Screening for Potentially Inappropriate Medications in the Elderly
PA PSRS Patient Saf Advis 2005 Dec;2(4):11-5.   
 

Prescribing medications for elderly patients presents many unique challenges. As we age, our bodies undergo physiologic changes that affect how medications are absorbed, distributed, metabolized, and eliminated. These changes often make elderly patients more sensitive to the effects of medications. However, there are criteria that can help practitioners reduce the risk of patient harm by guiding more appropriate drug selection in the elderly commonly known as the Beers Criteria.

Between 1960 and 1994, the number of persons aged 65 and older doubled, and individuals aged 85 years and older increased 274%.1 Today, people over age 65 account for 15% of the US population but consume more than one-third of all prescription and over-the-counter (OTC) medications.2,3 In Pennsylvania, 41% of patients admitted to the hospital are 65 years or older.4 It should therefore come as no surprise that patients over age 65 are involved in 41% of the adverse drug reaction reports and almost 60% of the medication-related fall reports submitted to PA-PSRS.

Pharmacodynamics in the Elderly5

As a person ages their total body water decreases while their relative percentage of body fat increases. These changes affect how some drugs are distributed in the body. The decrease in total body water can lead to higher blood concentrations of some water-soluble drugs. The relative increase in body fat may increase the total amount of drug stored in the body for lipid-soluble drugs and may result in longer half-lives of those medications. Some drugs bind to albumin in the blood stream, but with age, serum albumin levels decrease. This may enhance a drug’s effect by increasing serum concentrations of unbound (active) drug.

Many medications are metabolized by the liver. With age, decreased hepatic mass and hepatic blood flow can slow the rate of hepatic elimination. In addition, hepatic clearance of many drugs, such as diazepam, amitriptyline, and chlordiazepoxide, carried out by the cytochrome P-450 system often diminishes with age. Overall, the clearance of drugs metabolized by the liver is typically decreased 30 to 40% in the elderly.

Renal size and renal blood flow also decrease significantly with age. However, serum creatinine levels may remain within normal limits because the elderly have less lean body mass and produce less creatinine. These “normal” serum creatinine levels may mislead practitioners to believe that drug adjustments for renally excreted drugs are not necessary. However, this is often not the case, as these physiologic changes to the kidneys decrease renal clearance of drugs necessitating a dose adjustment.

Many drugs produce active metabolites in clinically significant concentrations. Examples include some benzodiazepines (e.g., diazepam, chlordiazepoxide), tertiary amine antidepressants (e.g., amitriptyline, imipramine), antipsychotics (e.g., chlorpromazine, thioridazine, risperidone), and opioid analgesics (e.g., meperidine, propoxyphene). Age-related decreases in renal clearance, particularly in patients with any additional renal disease, can lead to increased accumulation of these metabolites, increasing the risk of toxicity unless maintenance doses are reduced.

Adverse Drug Events and Beers Criteria

Many studies demonstrate the vulnerability of elderly patients to adverse drug events (ADEs) that may be due to the physiologic changes of aging. Problems in this population such as depression, constipation, falls, immobility, confusion, urinary retention, incontinence, anorexia, and hip fractures have been linked to preventable ADEs. One study showed that 30% of hospital admissions of elderly patients may be linked to drug-related problems including toxic effects.6,7 A 1997 study of ADEs found that 35% of ambulatory older adults experienced an ADE and 29% required health care services (physician, emergency department, or hospitalization) for the ADE.6 ADEs also affect drug regimen adherence in the elderly. A study of 20 elderly patients hospitalized due to non-adherence found that adverse effects were the most common reason (35%).8 Data from PA-PSRS show that 62% of medication-related falls that result in a Serious Event affected the elderly.

In 1991, 13 nationally recognized experts in geriatrics reached a consensus on explicit criteria for certain medications that may lead to ADEs and were considered to be inappropriate for use in nursing home patients. These criteria were originally developed by Dr. Mark Beers and are commonly referred to as the “Beers Criteria.” The criteria, most recently updated in 2003,9,10 are based on the risk-benefit definition of appropriateness, meaning that the use of a medication is considered to be appropriate if its use has potential benefits that outweigh potential risks.11

The Beers criteria define three categories of drug use or selection that are inappropriate for elderly patients. The categories, along with some examples are:

  1. Inappropriate drug choice, i.e., medications generally to be avoided in the elderly population. Examples include:
    1. Long-acting benzodiazepines, including diazepam (VALIUM), flurazepam (DALMANE), and chlordiazepoxide (LIBRIUM) which have long half-lives. This can lead to accumulation of the drug, leading to excessive sedation and an increase in the risk of falls and fractures.
    2. Meperidine (DEMEROL), which can cause confusion and its metabolites can lead to seizures.
    3. Anticholinergics and antihistamines, including diphenhydramine (BENADRYL), chlorpheniramine (CHLORTRIMETON), hydroxyzine (ATARAX, VISTARIL) and promethazine (PHENERGAN). These agents have potent anticholinergic effects and cause confusion and sedation. Diphenhydramine may be used in the lowest effective dose and only for emergency treatment of allergic reactions.
  2. Excess dosage, i.e., medications at a dose or duration of therapy not to be exceeded. Examples include:
    1. Long-term use of stimulant laxatives such as bisacodyl (DULCOLAX) and cascara sagrada, which may be appropriate in the presence of opiate analgesic use, but may exacerbate bowel dysfunction.
    2. Doses for digoxin (LANOXIN) should not exceed 0.125 mg/day except when treating atrial arrhythmias. Diminished renal clearance of this medication increases the risk of toxicity.
  3. Drug-disease interaction, i.e., medications to be avoided for patients with specific co-morbid conditions. Examples include:
    1. Patients with cognitive impairment receiving medications such as barbiturates, anticholinergics and muscle relaxants, which can worsen cognitive performance.
    2. Patients with a history of syncope or falls receiving medications such as short or intermediate-acting benzodiazepines and tricyclic antidepressants (amitriptyline [ELAVIL], doxepin [SINEQUAN], and imipramine [NORPRAMIN]) which may produce ataxia, impair psychomotor function, and increase falls.

The Beers criteria are intended for persons older than 65 years of age, regardless of their level of frailty. The criteria also provide a rating of severity for adverse outcomes (severe vs. less severe) as well as a summary of the prescribing concerns associated with the medication. An abbreviated list of these medications can be found in Table 1. A complete list is available at http://mqa.dhs.state.tx.us/qmweb/MedSim/MedSimTable1.htm.

Table 1. Abbreviated Beers List of Medications with Increased Risk of Adverse Drug Events in Patients Over 65

  Table 1. Abbreviated Beers List of Medications with
  Increased Risk of Adverse Drug Events in Patients Over 65

 

 

 

Today, the Beers criteria are the most widely used criteria for identifying drugs that potentially increase the likelihood of ADEs in elderly patients.12 The criteria were adopted by the Centers for Medicare & Medicaid Services (CMS) in July 1999 for evaluation of medication therapy in nursing home patients.

Numerous studies confirm that contraindicated medication use remains a serious problem for the elderly in a variety of healthcare settings.13-15 However, until recently, there was no published evidence demonstrating that the medications listed on the Beers criteria were actually associated with adverse outcomes. In Spring 2005, a study of the association between potentially contraindicated prescribing and hospitalization and death among elderly nursing home residents showed that:16

  1. The risk of hospitalization was almost 30% higher among residents who, in the preceding month, received potentially contraindicated medications that appear on the Beers criteria, and 33% higher among residents who received these medications for two consecutive months, compared with residents with no exposure.
  2. The odds of death in any month were 21% higher among residents who had exposure to these medications during the month of death or the preceding month, compared to those with no exposure.

A second study published this year showed a positive association between adverse drug reactions (ADRs) and drug prescribing practices that are contrary to the Beers criteria.12 Patients who experienced ADRs received a greater number of potentially inappropriate medications. In addition, there was a positive correlation between the number of ADRs and the number of prescribed drugs. The study also found a positive association between potentially inappropriate drug prescribing, as defined by the Beers criteria and ADRs, some of which were preventable, among elderly outpatients.

Analysis of PA-PSRS data shows that many reports of ADRs and falls involving the elderly cite a medication that appears on the Beers criteria, such as meperidine (DEMEROL), temazepam (RESTORIL), promethazine (PHENERGAN), and diphenhydramine (BENADRYL). Twenty percent (20%) of those ADR reports in patients over 65 describe patients receiving PHENERGAN (promethazine) and developing mental status changes such as agitation, “jitters,” and restlessness. Also, 58% of all medication-related falls in the elderly involve medications categorized as benzodiazepines or opiates, some of which may be contraindicated according to the Beers criteria.

Conclusion

The use of medications in the elderly population presents many challenges for all healthcare practitioners. Due to metabolic changes, the elderly are more prone to ADEs as well as ADRs. Though Beers’ 1991 criteria were developed for elderly nursing home residents and the 1997 criteria for community-dwelling elderly, these criteria can also be used in the acute care setting.  The latest studies suggest that many ADRs we attribute to medications in the elderly may actually be due to preventable ADEs. If the Beers criteria were followed, these ADRs may not have occurred.

The following practices may help to prevent ADEs and ADRs among the elderly:

  • Reviewing the medication profile upon admission and discharge against the Beers criteria. Consider substituting non-drug based treatments. For example, studies have shown that non-pharmacologic sleep protocols for inpatients are an effective means of reducing the use of sedatives and the risks of ADEs.17
  • Placing alerts into pharmacy order entry systems and computerized prescriber order entry systems for those medications on the Beers list that are prescribed for patients over age 65.
  • Increasing practitioner awareness of the Beers criteria through educational sessions and distributing laminated lists of the Beers criteria.
  • Monitoring elderly patients for ADRs and potential ADEs who are receiving medications that appear on the Beers criteria.
  • Identifying medications in your reports to PA-PSRS for those patients involved in falls to help identify those medications that are most problematic to this population.
  • Analyzing reports of ADRs, falls, and medication errors in your organization’s PA-PSRS reports for patients over age 65 to see if they were receiving medications that may not follow the Beers criteria.
  • When it is medically necessary to prescribe a drug to an elderly patient that is on the Beers criteria, consider starting at the lowest possible dose. For example, medications like PHENERGAN (promethazine) could be prescribed at doses as low as 6.25 mg, which may reduce the likelihood of an ADE.

By paying special attention to elderly patients who are receiving medications that appear on the Beers list we may be able to prevent ADEs and ADRs in this vulnerable population.

Notes

  1. Hobbs FB. The Elderly Population [online]. U.S. Census Bureau, Population Division and Housing and Household Economic Statistics Division. 18 Jan 2001. [Cited 18 Aug 2005.] Available from Internet: http://www.census.gov/population/www/pop-profile/elderpop.html.
  2. Querna E. Drugs for seniors: elderly patients should double-check their prescriptions [online]. USNews.com. 2 Nov 2004. [Cited 18 Aug 2005.] Available from Internet: http://www.usnews.com/usnews/health/briefs/seniorshealth/hb041102a.htm.
  3. US Food and Drug Administration. Medications and Older People [online]. Sep 2003. [Cited 18 Aug 2005.] Available from Internet: http://www.fda.gov/fdac/features/1997/697_old.html.
  4. Pennsylvania Health Care Cost Containment Council. County profile results, statewide report, utilization by age and sex [online]. 2004. [cited 19 Aug 2005.] Available from Internet: http://www.phc4.org.
  5. Clinical Pharmacology. In: Beers MH, ed. The Merck Manual of Geriatrics, 3rd Edition [online]. Whitehouse Station (NJ): Merck Research Laboratories; 2000. [Cited 18 Aug 2005.] http://www.merck.com/mrkshared/mmg/sec1/ch6/ch6b.jsp.
  6. Hanlon JT, Schmader KE, Kornkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997;45:945-8.
  7. Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997;157:2089-96.
  8. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990;150:841-5.
  9. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 1997;157:1531-6.
  10. Fick DM, Cooper, JW,Wade WE, et al. Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. Arch Intern Med 163:2716-24. December 2003.
  11. Beers MH, Ouslander JG, Rollingher J, Reuben DB, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991;151:1825-32
  12. Chang, CM. et al. Use of the Beers Criteria to Predict Adverse Drug Reactions among First-Visit Elderly Outpatients. Pharmacotherapy 2005;25(6):831-8
  13. Chin MH, Wang LC, Jin L, et al. Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med 1999; 6:1232-42.
  14. Aparasu RR, Fliginger SE. Inappropriate medication prescribing for the elderly by office-based physicians. Ann Pharmacother 1997;31:823-9.
  15. Schmader KE, Hanlon JT, Landsman PB, Samsa GP, Lewis IK, Weinberger M. Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann Pharmacother 1997;31:529-33
  16. Lau et al. Hospitalization and Death Associated With Potentially Inappropriate Medication Prescriptions Among Elderly Nursing Home Residents. Arch Intern Med 2005;165:68-74.
  17. McDowell JA, Mion LC, Lydon TJ, Inouye SK: A nonpharmacologic sleep protocol for hospitalized older patients. J.Am.Geriatr.Soc 1998; 46: 700-5.
 
 Browse by Topic
Navigation  



THE PENNSYLVANIA PATIENT SAFETY AUTHORITY AND ITS CONTRACTORS  
PSA LOGO The Pennsylvania Patient Safety Authority is an independent state agency created by Act 13 of 2002, the Medical Care Availability and Reduction of Error (“Mcare”) Act. Consistent with Act 13, ECRI Institute, as contractor for the Authority, is issuing this publication to advise medical facilities of immediate changes that can be instituted to reduce Serious Events and Incidents. For more information about the Pennsylvania Patient Safety Authority, see the Authority’s Web site at www.patientsafetyauthority.org .      
ECRI LOGO ECRI Institute, a nonprofit organization, dedicates itself to bringing the discipline of applied scientific research in healthcare to uncover the best approaches to improving patient care. As pioneers in this science for more than 40 years, ECRI Institute marries experience and independence with the objectivity of evidence-based research. More than 5,000 healthcare organizations worldwide rely on ECRI Institute’s expertise in patient safety improvement, risk and quality management, and healthcare processes, devices, procedures and drug technology.      

ISMP Logo The Institute for Safe Medication Practices (ISMP) is an independent, nonprofit organization dedicated solely to medication error prevention and safe medication use. ISMP provides recommendations for the safe use of medications to the healthcare community including healthcare professionals, government agencies, accrediting organizations, and consumers. ISMP’s efforts are built on a nonpunitive approach and systems-based solutions.      
 
©2014 Pennsylvania Patient Safety Authority                                                Home      Who We Are      Contact Us     Subscribe to Advisories and Press Releases   Site Map     Privacy Statement